A 52-Week Placebo-Controlled Trial of Evolocumab in HyperlipidemiaDirk Blom, Evan A. Stein, Phillip D. Toth et al.|New England Journal of Medicine|2014Cited by 712
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral DensityRobert R. Recker, Stephen L. Myers, Charles Benson et al.|Journal of Bone and Mineral Research|2014Cited by 291